Application of Evolving Evidence in Mantle Cell Lymphoma: Therapeutic Strategies Using BTK Inhibitors

Application of Evolving Evidence in Mantle Cell Lymphoma: Therapeutic Strategies Using BTK Inhibitors

Ondemand webcast of expert faculty presentation and case discussion on the current evidence of BTK inhibitors to treatment patient with mantle cell lymphoma

  • Provider:Clinical Care Options
  • Activity Link: https://clinicaloptions.com/CE-CME/hematology/btk-inhibitors-in-mantle-cell-lymphoma/26823-70234
  • Start Date: 2024-12-23 06:00:00
  • End Date: 2024-12-23 06:00:00
  • Credit Details: AMA PRA Category 1 Credit™️: 1.75 hours
  • MOC Credit Details: ABIM - 1.75 Point; Credit Type(s): Medical Knowledge (ABIM)
  • Commercial Support: Source: AstraZeneca (Any division) - Amount: 175000.0 - Is Kind Support: False
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: No, it's free
  • Measured Outcome: Learner Knowledge, Learner/Team Competence
  • Provider Ship: Directly Provided
  • Registration: Open to all
  • Specialty: Hematology, Medical Oncology
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.